Stručni rad - Ostalo
An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19
Clinical Drug Investigation, 41 (2021), 3; 287-289. https://doi.org/10.1007/s40261-021-01007-8


Povezani objekti
COVID-19 | Virtualna zbirka
Citirajte ovaj rad

Homolak, J., Kodvanj, I. i Trkulja, V. (2021). An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19. Clinical Drug Investigation, 41. (3), 287-289. doi: 10.1007/s40261-021-01007-8

Homolak, Jan, et al. "An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19." Clinical Drug Investigation, vol. 41, br. 3, 2021, str. 287-289. https://doi.org/10.1007/s40261-021-01007-8

Homolak, Jan, Ivan Kodvanj i Vladimir Trkulja. "An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19." Clinical Drug Investigation 41, br. 3 (2021): 287-289. https://doi.org/10.1007/s40261-021-01007-8

Homolak, J., Kodvanj, I. i Trkulja, V. (2021) 'An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19', Clinical Drug Investigation, 41(3), str. 287-289. doi: 10.1007/s40261-021-01007-8

Homolak J, Kodvanj I, Trkulja V. An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19. Clinical Drug Investigation [Internet]. 03.2021. [pristupljeno 28.11.2021.];41(3):287-289. doi: 10.1007/s40261-021-01007-8

J. Homolak, I. Kodvanj i V. Trkulja, "An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19", Clinical Drug Investigation, vol. 41, br. 3, str. 287-289, Ožujak 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:944205. [Citirano: 28.11.2021.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.